A novel technetium-99m radioligand for the 5-HT1A receptor derived from desmethyl-WAY-100635 (DWAY)


A novel technetium-99m radioligand for the 5-HT1A receptor derived from desmethyl-WAY-100635 (DWAY)

Heimbold, I.; Drews, A.; Syhre, R.; Kretzschmar, M.; Pietzsch, H.-J.; Johannsen, B.

This paper reports the synthesis, biological evaluation and in vitro autoradiography of a new technetium-99m radioligand with high affinity for the 5-HT1A receptor. The neutral complex combines an N2S2 diamine dithiol (DADT) ligand as complexing moiety for oxotechnetium(V) and a 2-(1-piperazino)phenol via a 6-carbon alkyl chain, derived from desmethyl-WAY-100635 (DWAY). The complex displays an IC50 value for the 5-HT1A receptor of 1.29 nM against the selective 5-HT1A agonist [3H]8-OH-DPAT, a moderate selectivity towards the alpha1-adrenergic receptor (IC50 of 8.1 nM against [3H]prazosin) and a good selectivity for the D2 receptor (IC50 of 192 nM against [3H]spiperone) and the 5-HT2A receptor (IC50 of 922 nM against [3H]ketanserin). Biodistribution studies in rats show an initial brain uptake of 0.65%±0.07% ID 2.5 min p.i. In vitro autoradiographic studies of the 99mTc complex in rat brains indicate a strong specific accumulation of the radioactivity in 5-HT1A receptor-rich brain regions.

Keywords: 5-HT1A receptor; technetium-99m; 99mTc receptor ligand; DWAY analogue; radioligand

  • European Journal of Nuclear Medicine 29 (2002) 82-87

Permalink: https://www.hzdr.de/publications/Publ-4283